Bandingkan Harga & Kinerja Goodyear Indonesia Tbk. (GDYR) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Goodyear Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Goodyear Indonesia Tbk. diperdagangkan di Rp1.130 (kapitalisasi pasar 457,15 M, volume 24 jam 2,4 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Goodyear Indonesia Tbk. jauh lebih besar — sekitar 4,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GDYR | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 457,15 M | 104,4 M |
Volume | 2,4 rb | — |
Lot | 24 | — |
Perputaran | 2,7 jt | — |
Harga Rata-rata | 1.124,79 | — |
Nilai Transaksi | 2,7 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Goodyear Indonesia Tbk.
PT Goodyear Indonesia Tbk (the Company) was established on January 6, 1917 under the name “NV The Goodyear Tire & Rubber Company Limited” and changed its name to “PT Goodyear Indonesia” on July 25, 1978. On November 10, 1980, the Company obtained approval from the Capital Market Supervisory Board (BAPEPAM) to offer a portion of its shares to the public through the Indonesia Stock Exchange. Effective December 22, 1980, 6,150,000 shares of the Company with total par value of Rp 6,150,000 (equivalent to 15% of the total issued and outstanding shares) were officially listed in Jakarta Stock Exchange.
Selengkapnya di halaman GDYR →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
